Adalimumab Therapy Achieves Clinical Remission and Response at Week 26 in Chinese Patients with Crohn's Disease

被引：1
|
作者：
Wu, Kai-Chun [1 ]
Ran, Zhi Hua [2 ]
Gao, Xiang [3 ]
Chen, Minhu [4 ]
Zhong, Jie [5 ]
Sheng, Jian-Qiu [6 ]
Kamm, Michael A. [7 ,8 ]
Travis, Simon [9 ,10 ]
Robinson, Anne M.
Wallace, Kori
Shapiro, Marisa
Li, Yao
Thakkar, Roopal B.
机构：
[1] Fourth Mil Med Univ, Xijing Hosp, Xian, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Renji Hosptial, Huangpu, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
[5] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai, Peoples R China
[6] Beijing PLA, Mil Gen Hosp, Beijing, Peoples R China
[7] St Vincents Hosp Melbourne, Parkville, Vic, Australia
[8] Univ Melbourne, Parkville, Vic, Australia
[9] John Radcliffe Hosp, Oxford, England
[10] AbbVie Inc, N Chicago, IL USA
来源：
INFLAMMATORY BOWEL DISEASES | 2016年 / 22卷
关键词：
D O I：
10.1097/01.MIB.0000480212.77049.85
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P-107
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [41] Optimising infliximab induction dosing to achieve clinical remission in Chinese patients with Crohn's disease
    Zhu, Kouzhu
    Ding, Xiaoliang
    Xue, Ling
    Liu, Linsheng
    Wang, Yan
    Li, Yun
    Xi, Qinhua
    Pang, Xueqin
    Chen, Weichang
    Miao, Liyan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [42] Sustained clinical remission in patients with moderate to severe Crohn's disease with adalimumab, regardless of anti-TNF history or concomitant immunosuppressant therapy
    Hanauer, Stephen B.
    D'Haens, G. R.
    Colombel, J. F.
    Sandborn, W. J.
    Rutgeerts, P.
    Kent, J. D.
    Pollack, P. F.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S457 - S457
  • [43] Remission and clinical response induced and maintained in patients with active Crohn's disease treated for 1-year open-label with adalimumab
    Sandborn, WJ
    Hanauer, SB
    Lukas, M
    Wolf, DC
    Isaacs, KL
    MacIntosh, DG
    Panaccione, R
    Rutgeerts, P
    Pollack, PF
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S316 - S317
  • [44] ACHIEVING BIOCHEMICAL REMISSION IN CROHN'S DISEASE WITH ADALIMUMAB THERAPY UTILSING THERAPEUTIC DRUG MONITORING
    Plevris, Nikolas
    Jenkinson, Phil
    Lyons, Matthew
    Jones, Gareth
    Chuah, Cher
    Hall, Rebecca
    Deekae, Adepeju
    Merchant, Lynne
    Pattenden, Rebecca
    Din, Shahida
    Watson, Eleanor
    Shand, Alan
    Noble, Colin
    Arnott, Ian
    Lees, Charlie
    GUT, 2018, 67 : A63 - A63
  • [45] Muscle performance in patients with Crohn's disease in clinical remission
    Wiroth, JB
    Filippi, J
    Schneider, SM
    Al-Jaouni, R
    Horvais, N
    Gavarry, O
    Bermon, W
    Hébuterne, X
    INFLAMMATORY BOWEL DISEASES, 2005, 11 (03) : 296 - 303
  • [46] Sarcopenia Is Prevalent in Patients with Crohn's Disease in Clinical Remission
    Schneider, Stephane M.
    Al-Jaouni, Rima
    Filippi, Jerome
    Wiroth, Jean-Baptiste
    Zeanandin, Gilbert
    Arab, Kamel
    Hebuterne, Xavier
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (11) : 1562 - 1568
  • [47] Safety of Adalimumab in Global Clinical Trials of Patients with Crohn's Disease
    Colombel, Jean-Frederic
    Rutgeerts, Paul
    Sandborn, William J.
    Rutgeerts, Paul J.
    Hanauer, Stephen B.
    Reinisch, Walter
    Pollack, Paul F.
    Kent, Jeffrey D.
    Cardoso, Alexandra T.
    Lau, Winnie
    GASTROENTEROLOGY, 2009, 136 (05) : A651 - A651
  • [48] Adalimumab Safety in Global Clinical Trials of Patients with Crohn's Disease
    Colombel, Jean-Frederic
    Sandborn, William J.
    Panaccione, Remo
    Robinson, Anne M.
    Lau, Winnie
    Li, Ju
    Cardoso, Alexandra T.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (09) : 1308 - 1319
  • [49] Safety of Adalimumab in Global Clinical Trials of Patients with Crohn's Disease
    Colombel, Jean-Frederic
    Panaccione, Remo
    Sandborn, William
    Rutgeerts, Paul
    Hanauer, Stephen
    Reinisch, Walter
    Robinson, Anne
    Lau, Winnie
    Cardoso, Alexandra
    Pollack, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S413 - S414
  • [50] Impact of Adalimumab therapy after 12 Weeks in patients with Crohn's Disease who were nonresponders at week 4
    Panaccione, R.
    Sandborn, W.
    Colombel, J.
    Pollack, P.
    Chen, N.
    Chao, J.
    Mulani, P.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (12) : S28 - S28
12345